Tivic Health Systems 株価情報 (NASDAQ: TIVC)

最新ニュース Tivic Health Systems (NASDAQ:TIVC) 株価情報

Tivic Health Systems

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

Movers

Trading Ideas

BIMI

DALN

FFIE

FGEN

GRPN

JTAI

LMND

MGNX

NUZE

PITA

PMEC

POWL

TBIO

TIVC

アドバンスト マイクロ デバイセズ社 (NASDAQ:AMD) の株は、予想を上回る第2四半期決算を受けて本日のプレマーケット取引で急騰している。

AMD株価上昇　決算を受けて

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems Inc

Mizuho analyst Gregg Moskowitz maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Outperform and raises the price target from $190 to $205.

News

Price Target

Analyst Ratings

SNOW

Mizuho Maintains Outperform on Snowflake, Raises Price Target to $205

Zelman &amp; Assoc initiates coverage on Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) with a Underperform rating.

Initiation

Zelman & Assoc Initiates Coverage On Williams-Sonoma with Underperform Rating

Mizuho analyst Gregg Moskowitz maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Outperform and lowers the price target from $425 to $380.

Mizuho Maintains Outperform on Salesforce, Lowers Price Target to $380

MAIA Biotechnology, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAIA#NYSE">MAIA</a>), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an abstract about the efficacy data from the Phase 2 THIO-101 clinical trial was accepted for poster presentation at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3, 2025, in Chicago, Illinois. The poster is scheduled for presentation on May 31, 2025, from 01:30pm to 04:30pm CDT in the Lung Cancer track.

Biotech

General

MAIA

MAIA Biotechnology Announces That An Abstract About The Efficacy Data From The Phase 2 THIO-101 Clinical Trial Was Accepted For Poster Presentation At The 2025 Annual Meeting Of The ASCO, Taking Place May 30 To June 3, 2025

Zelman &amp; Assoc initiates coverage on Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Outperform rating.

Zelman & Assoc Initiates Coverage On Wayfair with Outperform Rating

TURO

UBER

Turo And Uber Partner To Offer Turo Vehicle Rentals Directly Through The Uber App In The U.S

Mizuho analyst Gregg Moskowitz maintains SailPoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIL#NASDAQ">SAIL</a>) with a Neutral and lowers the price target from $25 to $24.

SAIL

Mizuho Maintains Neutral on SailPoint, Lowers Price Target to $24

ARAI

Arrive AI Shares Shares Resume Trade Then Again Halted On Circuit Breaker At $31.05/Share

Mizuho analyst Gregg Moskowitz maintains Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Outperform and raises the price target from $127 to $135.

OKTA

Mizuho Maintains Outperform on Okta, Raises Price Target to $135

Mizuho analyst Gabriel Moreen maintains UGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGI#NYSE">UGI</a>) with a Outperform and raises the price target from $38 to $39.

Mizuho Maintains Outperform on UGI, Raises Price Target to $39

Mizuho analyst Gabriel Moreen maintains New Jersey Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NJR#NYSE">NJR</a>) with a Neutral and lowers the price target from $52 to $50.

Mizuho Maintains Neutral on New Jersey Resources, Lowers Price Target to $50

Joanne Barbara Edwards, Director at Standex International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXI#NYSE">SXI</a>), disclosed an insider sell on May 14, according to a recent SEC filing.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000310354/000112760225014313//Archives/edgar/data/310354/000112760225014313/0001127602-25-014313-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, Edwards sold 355 shares of Standex International. The total transaction value is $55,426.
The latest market snapshot at Thursday morning reveals Standex International shares down by 0.0%, trading at $156.59.
<h3>Discovering Standex International: A Closer Look</h3>
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.
<h3>Standex International's Financial Performance</h3>
Revenue Growth: Standex International's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 17.21%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: With a high gross margin of 39.67%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 1.83, Standex International showcases strong earnings per share.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 0.91, Standex International faces challenges in effectively managing its debt levels, indicating potential financial strain.
Valuation Analysis:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 31.01, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 2.51 is above industry norms, reflecting an elevated valuation for Standex International's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 20.6, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Navigating the World of Insider Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000310354">Check Out The Full List Of Standex International's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Decision: Joanne Barbara Edwards Offloads $55K Worth Of Standex International Stock

Mark W Peterson, Chief Administrative Officer at Zurn Elkay Water Solns (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZWS#NYSE">ZWS</a>), executed a substantial insider sell on May 14, according to an SEC filing.
What Happened: Peterson's decision to sell 7,000 shares of Zurn Elkay Water Solns was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001439288/000143928825000091//Archives/edgar/data/1439288/000143928825000091/0001439288-25-000091-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The total value of the sale is $261,170.
Tracking the Thursday's morning session, Zurn Elkay Water Solns shares are trading at $36.88, showing a down of 0.0%.
<h3>Delving into Zurn Elkay Water Solns's Background</h3>
Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.
<h3>Zurn Elkay Water Solns's Economic Impact: An Analysis</h3>
Revenue Growth: Zurn Elkay Water Solns's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 4.01%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 46.55%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Zurn Elkay Water Solns's EPS reflects a decline, falling below the industry average with a current EPS of 0.26.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.36.
Valuation Analysis:
<ul>
<li>
Price to Earnings (P/E) Ratio: Zurn Elkay Water Solns's current Price to Earnings (P/E) ratio of 38.42 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 4.05 is above industry norms, reflecting an elevated valuation for Zurn Elkay Water Solns's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 19.4, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001439288">Check Out The Full List Of Zurn Elkay Water Solns's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Chief Administrative Officer At Zurn Elkay Water Solns Sells $261K Of Stock

On May 14, a substantial insider purchase was made by David P Bozeman, Board Member at 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), as per the latest SEC filing.
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000066740/000112760225014319//Archives/edgar/data/66740/000112760225014319/0001127602-25-014319-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, Bozeman increased their investment in 3M by purchasing 1,297 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $195,000.
At Thursday morning, 3M shares are down by 0.16%, trading at $147.64.
<h3>About 3M</h3>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>3M: Financial Performance Dissected</h3>
Revenue Growth: 3M's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -1.03%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 41.59%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): 3M's EPS is below the industry average. The company faced challenges with a current EPS of 2.05. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: 3M's debt-to-equity ratio is notably higher than the industry average. With a ratio of 3.15, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 18.42 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 3.32 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a lower-than-industry-average EV/EBITDA ratio of 11.39, 3M presents a potential value opportunity, as investors are paying less for each unit of EBITDA.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Cracking Transaction Codes</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000066740">Check Out The Full List Of 3M's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Move: David P Bozeman Invests $195K In 3M Stock

A notable insider purchase on May 14, was reported by Thomas K Brown, Director at 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), based on the most recent SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000066740/000112760225014324//Archives/edgar/data/66740/000112760225014324/0001127602-25-014324-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday unveiled that Brown made a notable purchase of 1,297 shares of 3M, valuing at $195,000.
During Thursday's morning session, 3M shares down by 0.16%, currently priced at $147.64.
<h3>About 3M</h3>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>3M: Delving into Financials</h3>
Revenue Challenges: 3M's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -1.03%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 41.59%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): 3M's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 2.05.
</li>
</ul>
Debt Management: 3M's debt-to-equity ratio surpasses industry norms, standing at 3.15. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 18.42 is lower than the industry average, implying a discounted valuation for 3M's stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 3.32 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): 3M's EV/EBITDA ratio at 11.39 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000066740">Check Out The Full List Of 3M's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Bullish Move: Thomas K Brown Shows Confidence, Acquires $195K In 3M Stock

Disclosed in the latest SEC filing, a significant insider purchase on May 14, involves Audrey Choi, Director at 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>).
What Happened: Choi made a significant move by purchasing 1,297 shares of 3M as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000066740/000112760225014326//Archives/edgar/data/66740/000112760225014326/0001127602-25-014326-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $195,000.
3M shares are trading down 0.16% at $147.64 at the time of this writing on Thursday morning.
<h3>Get to Know 3M Better</h3>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>Financial Insights: 3M</h3>
Negative Revenue Trend: Examining 3M's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -1.03% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: With a high gross margin of 41.59%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, 3M exhibits below-average bottom-line performance with a current EPS of 2.05.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 3.15, caution is advised due to increased financial risk.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 18.42 is lower than the industry average, implying a discounted valuation for 3M's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 3.32, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry benchmarks at 11.39, 3M presents an attractive value opportunity.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000066740">Check Out The Full List Of 3M's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

3M Director Trades $195K In Company Stock

IREN Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) stock is trading lower on Thursday. The company reported third-quarter earnings after the <a href="https://www.benzinga.com//node/45422970">bell on Wednesday.</a>
What To Know: IREN reported earnings per share of 11 cents, missing the consensus estimate of 14 cents. In addition, IREN reported sales of $148.10 million, missing the consensus estimate of $159.37 million.
The company broke down its revenue, reporting a 24% quarter-over-quarter increase in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) mining revenue to $141.2 million. AI Cloud services revenue rose 33% from the second quarter to $3.6 million.
Daniel Roberts, co-founder and co-CEO of IREN, said, "We're pleased to report another quarter of strong EBITDA and net profit. Our focus on large-scale data center sites continues to drive rapid growth and strong margins.&#8221;
IREN mined 1,514 Bitcoin during the quarter with an average operating hashrate of 29.4 EH/s. The company hit 40 EH/s on April 16 and expects to reach 50 EH/s by June 30.
Analyst Changes: Following the earnings report, multiple analysts issued price target adjustments.
<ul class="wp-block-list">
<li>Macquarie analyst Paul Golding maintained an Outperform rating on IREN and raised the price target from&nbsp;$15.5&nbsp;to&nbsp;$20.</li>
<li>HC Wainwright &amp; Co. analyst Mike Colonnese maintained a Buy rating on IREN and lowered the price target from&nbsp;$22&nbsp;to&nbsp;$21.</li>
</ul>
Related Link: <a href="https://www.benzinga.com/insights/short-sellers/25/05/45436162/is-paylocity-holding-gaining-or-losing-market-support">Is Paylocity Holding Gaining or Losing Market Support?</a>
IREN Price Action: At the time of writing, IREN shares are trading 7.09% lower at $7.40, according to data from <a href="https://www.benzinga.com/pro/login">Benzinga Pro</a>.
Image: via Shutterstock

$BTC

IREN

IREN Stock Is Slipping Thursday: What's Going On?

Anne H Chow, Director at 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), disclosed an insider purchase on May 14, based on a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000066740/000112760225014328//Archives/edgar/data/66740/000112760225014328/0001127602-25-014328-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that Chow purchased 1,297 shares of 3M. The total transaction amounted to $195,000. 
Tracking the Thursday's morning session, 3M shares are trading at $147.64, showing a down of 0.16%.
<h3>About 3M</h3>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>Key Indicators: 3M's Financial Health</h3>
Decline in Revenue: Over the 3 months period, 3M faced challenges, resulting in a decline of approximately -1.03% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 41.59%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): 3M's EPS reflects a decline, falling below the industry average with a current EPS of 2.05.
</li>
</ul>
Debt Management: 3M's debt-to-equity ratio is notably higher than the industry average. With a ratio of 3.15, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 18.42 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 3.32 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio of 11.39 trails industry averages, indicating a potential disparity in market valuation that could be advantageous for investors.
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
When analyzing transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase,while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000066740">Check Out The Full List Of 3M's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eye On Growth: Anne H Chow Adds $195K Of 3M Stock To Portfolio

It was revealed in a recent SEC filing that James R Fitterling, Board Member at 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) made a noteworthy insider purchase on May 14,.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000066740/000112760225014332//Archives/edgar/data/66740/000112760225014332/0001127602-25-014332-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that Fitterling purchased 1,297 shares of 3M. The total transaction amounted to $195,000. 
In the Thursday's morning session, 3M's shares are currently trading at $145.02, experiencing a down of 1.93%.
<h3>Unveiling the Story Behind 3M</h3>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>Breaking Down 3M's Financial Performance</h3>
Revenue Growth: 3M's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -1.03%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 41.59%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): 3M's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 2.05.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 3.15, 3M faces challenges in effectively managing its debt levels, indicating potential financial strain.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: 3M's P/E ratio of 18.42 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 3.32, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 11.39 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>A Deep Dive into Insider Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000066740">Check Out The Full List Of 3M's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

3M Board Member Trades $195K In Company Stock

A new SEC filing reveals that Suzan Kereere, Director at 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), made a notable insider purchase on May 14,.
What Happened: Kereere demonstrated confidence in 3M by purchasing 1,297 shares, as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000066740/000112760225014335//Archives/edgar/data/66740/000112760225014335/0001127602-25-014335-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The total value of the transaction is $195,000.
3M's shares are actively trading at $145.02, experiencing a down of 1.93% during Thursday's morning session.
<h3>Get to Know 3M Better</h3>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>3M: Delving into Financials</h3>
Decline in Revenue: Over the 3 months period, 3M faced challenges, resulting in a decline of approximately -1.03% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: With a high gross margin of 41.59%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): 3M's EPS is below the industry average. The company faced challenges with a current EPS of 2.05. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: 3M's debt-to-equity ratio surpasses industry norms, standing at 3.15. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: 3M's P/E ratio of 18.42 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 3.32, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry benchmarks at 11.39, 3M presents an attractive value opportunity.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Important Transaction Codes</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000066740">Check Out The Full List Of 3M's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Major Purchase Alert: Suzan Kereere Invests $195K In 3M Stock

Press Releases

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth

$2 Stocks to Watch: PNPN.V, TIVC, APVO, OSRH, PRSO Biotech Breakthroughs, MedTech Momentum Metallic Metals Power Play & Signal Innovation

Tivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

Tivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of Neutropenia

Tivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates

SmallCaps Gaining Momentum: TIVC, GELS, SLI, OBIO in Healthcare, Biotech, Energy, Military Defense, Etc. – More Stocks Inside

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

Tivic Expands VNS Intellectual Property Portfolio

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

APVO

GELS

OBIO

OSRH

PNPNF

PRSO

SCPX

Aethlon Medical

Autonomix Medical

Bluejay Diagnostics

GlucoTrack

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Know Labs

LogicMark

NanoVibronix

ENDRA Life Sciences

Nuwellis

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Technologies

Tenon Medical

Venus Concept

Catheter Precision

アドバンスト マイクロ デバイセズ社 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) の株は、予想を上回る<a href="https://www.benzinga.com/news/earnings/24/07/40060832/amd-skyrockets-over-9-lifting-along-with-ai-rival-nvidia-whats-going-on">第2四半期決算</a>を受けて本日のプレマーケット取引で急騰している。
AMDは1株あたり69セントの四半期決算を報告し、これはアナリストの予想一致値である1株あたり68セントを上回った。また同社は、1株あたり5.8350億ドルの四半期売上を報告し、これはアナリストの予想一致値である1株あたり5.7240億ドルを上回った。これは<a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>のデータによるものだ。
AMDの株はプレマーケット取引で9.1％上昇し、151.01ドルになった。
以下は、プレマーケットで動いた他の銘柄の一部である。
<h3 class="wp-block-heading">上昇銘柄</h3>
<ul>
<li>Primech Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMEC#NASDAQ">PMEC</a>) の株は、火曜日に5％以上上昇した後プレマーケット取引で114.8％上昇し、1.13ドルになった。</li>
<li>Heramba Electric plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PITA#NASDAQ">PITA</a>) の株は、火曜日に約49％下落した後、本日のプレマーケット取引で92.8％上昇し、8.29ドルになった。</li>
<li>NuZee, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) の株は、火曜日に約3％上昇した後、本日のプレマーケット取引で79.4％上昇し、6.64ドルになった。</li>
<li>Telesis Bio, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) の株は、プレマーケット取引で39.8％上昇し、5.52ドルとなった。</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) の株は、同社がナスダックの規制順守を回復した後、前日の取引で33.1％上昇したプレマーケット取引で0.4205ドルになった。</li>
<li>Powell Industries, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) の株は、3四半期の決算が予想を上回った後、プレマーケット取引で25.3％上昇し、167.02ドルになった。</li>
<li>BIMI Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) の株は、火曜日に約66％下落した後、プレマーケット取引で22.8％上昇し、0.48ドルになった。</li>
<li>DallasNews Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DALN#NASDAQ">DALN</a>) の株は、同社が第2四半期の財務決算で前年同期比で増収を報告した後、プレマーケット取引で19.1％上昇し、3.91ドルになった。</li>
<li>Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) の株は、同社がコマンチピーク原子力発電所の運営期間を2053年まで延長する許可を米原子力規制委員会から取得した後、プレマーケット取引で12.1％上昇し、77.35ドルになった。</li>
</ul>
<h3 class="wp-block-heading">下落銘柄</h3>
<ul>
<li>FibroGen, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) の株は、プレマーケット取引で40.2％下落し、0.6159ドルになった。同社は、膵臓がん患者におけるパムレブルマブの有効性と安全性を評価する2つの後期試験からの最上位結果を発表し、および転移性膵臓がん患者におけるパンブロキシマブの臨床データを報告した。</li>
<li>MacroGenics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) の株は、2024年の欧州医療腫瘍学会議での2相試験のプレゼンテーションを発表した後、プレマーケット取引で24.0％下落し、3.99ドルになった。</li>
<li>Jet.AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) の株は、ワラントに関する交換オファーと同意勧誘の結果を発表した後、プレマーケット取引で21.5％下落し、0.2631ドルになった。</li>
<li>Velo3D, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLD#NYSE">VLD</a>) の株は、火曜日に4％下落した後、プレマーケット取引で20.6％下落し、2.20ドルになった。</li>
<li>Penumbra, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) の株は、同社が第2四半期の決算を発表し、自社の2024会計年度の売上高予測の下方修正を行った後、プレマーケット取引で20.3％下落し、137.93ドルになった。</li>
<li>Groupon, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) の株は、第2四半期の一株当たり利益が予想を下回ったことを受け、プレマーケット取引で18.6％下落し、12.75ドルになった。</li>
<li>Definitive Healthcare Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) の株は、NeedhamのアナリストRyan MacDonald氏が同社の投資判断を「ホールド」に継続したことにより、プレマーケット取引で17.6％下落し、4.71ドルになった。</li>
<li>O-I Glass, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OI#NYSE">OI</a>) の株は、プレマーケット取引で15.5％下落し、9.80ドルになった。同社は2024年の業績見通しを下方修正した。</li>
<li>Lemonade, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) の株は、四半期決算を発表した後、プレマーケット取引で14.6％下落し、19.33ドルになった。</li>
<li>Tivic Health Systems, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) の株は、火曜日に約18％下落した後、プレマーケット取引で12.4％下落し、0.5056ドルになった。</li>
</ul>

Comments

Tivic Health Systems

ニュース

最新ニュース Tivic Health Systems (NASDAQ:TIVC) 株価情報

水曜日, 7 31, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル